ClinicalTrials.gg
Active, not recruitingNCT07584863Updated May 13, 2026

Virtual Reality-Based Simulation Versus High-Fidelity Simulation for Emergency Management Training in Medical Interns

An interventional study of Virtual Reality-Based Emergency Simulation and High-Fidelity Simulation in Anaphylaxis and Hypoxia, sponsored by Seoul National University Hospital. Active, not recruiting at 1 site in South Korea. Per ClinicalTrials.gov, last updated 2026-05-13.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
124
Allocation
Randomized
Sex
All
01

Study summary

This study is a two-arm parallel randomized controlled non-inferiority trial designed to compare the educational effectiveness of virtual reality (VR)-based simulation with high-fidelity simulation (HFS) for emergency management training in medical interns.

Participants will be randomized 1:1 to either VR-based training or HFS-based training for managing desaturation and anaphylaxis scenarios. After training and structured debriefing, all participants will undergo objective structured clinical examinations (OSCEs) and complete pre- and post-training surveys.

The primary outcome is OSCE performance score. Secondary outcomes include confidence improvement, participant satisfaction, usability (UEQ-S).

02

Conditions studied

  • Anaphylaxis
  • Hypoxia

Keywords

  • Virtual Reality
  • High-Fidelity Simulation
  • Medical Education
  • OSCE
  • Emergency Training
  • Anaphylaxis
  • Desaturation
  • Simulation-Based Education
03

In context

Anaphylaxis

100 studies on the registry are indexed under Anaphylaxis; 20 are open to participants now.

This study's planned enrollment of 124 is above the median of 40 across 50 interventional studies indexed under Anaphylaxis.

Browse Anaphylaxis studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Medical interns enrolled in the 2026 internship program at Seoul National University Hospital
  • Provided written

Exclusion criteria

Exclusion Criteria

  • Did not complete pre-training survey
  • Declined participation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
124 participants (estimated)

Study arms

  • Experimental
    VR Group

    Participants use an immersive VR platform to manage simulated patients with oxygen desaturation and anaphylaxis.

    Behavioral: Virtual Reality-Based Emergency Simulation

  • Active comparator
    HFS Group

    Participants use a high-fidelity simulator (Sim-Man) to manage the same emergency scenarios.

    Behavioral: High-Fidelity Simulation

Interventions

  • BehavioralVirtual Reality-Based Emergency Simulation

    Participants use an immersive VR platform to manage simulated patients with oxygen desaturation and anaphylaxis.

  • BehavioralHigh-Fidelity Simulation

    Participants use a high-fidelity simulator (Sim-Man) to manage the same emergency scenarios.

06

What researchers measure

Primary outcomes

  1. OSCE Performance Score

    Mean total score of two Objective Structured Clinical Examination (OSCE) stations (desaturation and anaphylaxis). Scores range from 0 to 20, with higher scores indicating better clinical performance.

    Time frame: Immediately after training

Secondary outcomes

  1. Confidence Improvement

    Self-reported confidence in emergency management measured using a 10-point Likert scale ranging from 1 to 10, with higher scores indicating greater confidence.

    Time frame: Immediately before and immediately after training

  2. Participant Satisfaction

    Participant satisfaction measured using a 7-point Likert scale ranging from 1 to 7, with higher scores indicating greater satisfaction.

    Time frame: Immediately after training

  3. Usability (UEQ-S)

    Usability assessed using the User Experience Questionnaire-Short Version (UEQ-S). Scores range from 1 to 7, with higher scores indicating a more positive user experience.

    Time frame: Immediately after training

Other outcomes

  1. Task Completion Time

    Time required to complete VR emergency scenarios, measured in seconds.

    Time frame: Immediately after training

  2. Critical Action Completion Rate

    Percentage of predefined critical actions successfully completed during VR scenarios.

    Time frame: Immediately after training

  3. Task Sequence Accuracy

    Accuracy of procedural task sequence during VR emergency scenarios based on predefined scenario flow.

    Time frame: Immediately after training

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07584863
Responsible party
Sun Jung Myung (Professor, Seoul National University Hospital) — Principal investigator
First posted
May 13, 2026
Start date
Feb 20, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
May 13, 2026

Study contacts

Sun Jung Myung
principal investigator · Seoul National University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion